Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Congenital Hypothyroidism | 14 | 2023 | 79 | 5.500 |
Why?
|
Thyroid Hormones | 55 | 2020 | 327 | 5.050 |
Why?
|
Thyroid Hormone Resistance Syndrome | 33 | 2020 | 117 | 4.410 |
Why?
|
Receptors, Thyroid Hormone | 36 | 2011 | 160 | 3.440 |
Why?
|
Thyroid Gland | 29 | 2024 | 275 | 2.950 |
Why?
|
Iodide Peroxidase | 12 | 2023 | 205 | 2.830 |
Why?
|
Thyroid Hormone Receptors beta | 21 | 2017 | 81 | 2.700 |
Why?
|
Thyroxine | 42 | 2021 | 347 | 2.680 |
Why?
|
Mutation | 44 | 2024 | 4097 | 2.450 |
Why?
|
Thyrotropin | 50 | 2024 | 286 | 2.450 |
Why?
|
Triiodothyronine | 45 | 2021 | 341 | 2.370 |
Why?
|
Iron-Binding Proteins | 3 | 2021 | 15 | 2.170 |
Why?
|
Thyroglobulin | 6 | 2020 | 59 | 2.160 |
Why?
|
Thyroid Hormone Receptors alpha | 12 | 2020 | 22 | 2.060 |
Why?
|
Autoantigens | 3 | 2021 | 129 | 2.020 |
Why?
|
Mutation, Missense | 6 | 2020 | 276 | 1.860 |
Why?
|
Pedigree | 44 | 2024 | 968 | 1.420 |
Why?
|
Symporters | 17 | 2021 | 105 | 1.380 |
Why?
|
Thyroid Diseases | 12 | 2020 | 105 | 1.260 |
Why?
|
Thyroid Function Tests | 26 | 2021 | 120 | 1.230 |
Why?
|
Heterozygote | 10 | 2021 | 372 | 1.210 |
Why?
|
Transcription Factors | 14 | 2009 | 1645 | 1.190 |
Why?
|
Pituitary Gland | 13 | 2012 | 119 | 1.160 |
Why?
|
Adrenocorticotropic Hormone | 8 | 2012 | 131 | 1.130 |
Why?
|
Membrane Transport Proteins | 10 | 2017 | 169 | 1.000 |
Why?
|
Muscle Hypotonia | 6 | 2021 | 45 | 0.960 |
Why?
|
Awards and Prizes | 1 | 2023 | 37 | 0.890 |
Why?
|
Mice, Knockout | 34 | 2017 | 1987 | 0.890 |
Why?
|
Phenotype | 22 | 2021 | 2434 | 0.880 |
Why?
|
Male | 109 | 2024 | 41953 | 0.850 |
Why?
|
Thyrotropin, beta Subunit | 3 | 2020 | 10 | 0.840 |
Why?
|
Dual Oxidases | 2 | 2020 | 14 | 0.840 |
Why?
|
Liver | 16 | 2015 | 1241 | 0.800 |
Why?
|
Histone Acetyltransferases | 10 | 2009 | 42 | 0.800 |
Why?
|
Point Mutation | 14 | 2012 | 246 | 0.790 |
Why?
|
Monocarboxylic Acid Transporters | 14 | 2021 | 80 | 0.780 |
Why?
|
Pituitary ACTH Hypersecretion | 5 | 2012 | 11 | 0.780 |
Why?
|
Humans | 137 | 2024 | 88482 | 0.780 |
Why?
|
Biological Products | 1 | 2023 | 147 | 0.770 |
Why?
|
Muscular Atrophy | 5 | 2021 | 43 | 0.770 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2011 | 81 | 0.750 |
Why?
|
Female | 90 | 2024 | 45687 | 0.730 |
Why?
|
Hyperthyroidism | 7 | 2017 | 75 | 0.730 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 7 | 2003 | 186 | 0.710 |
Why?
|
Alu Elements | 1 | 2020 | 15 | 0.710 |
Why?
|
Mutagenesis, Insertional | 1 | 2020 | 112 | 0.680 |
Why?
|
Hypothyroidism | 15 | 2013 | 235 | 0.650 |
Why?
|
Hydrocortisone | 6 | 2006 | 303 | 0.650 |
Why?
|
Protein Multimerization | 1 | 2020 | 173 | 0.640 |
Why?
|
DNA-Binding Proteins | 5 | 2021 | 1239 | 0.620 |
Why?
|
Adrenal Glands | 3 | 2006 | 77 | 0.610 |
Why?
|
Mental Retardation, X-Linked | 4 | 2021 | 24 | 0.610 |
Why?
|
Child | 30 | 2020 | 7081 | 0.590 |
Why?
|
Energy Metabolism | 5 | 2015 | 278 | 0.580 |
Why?
|
Mice | 46 | 2017 | 11700 | 0.570 |
Why?
|
Goiter | 5 | 2018 | 43 | 0.560 |
Why?
|
Nuclear Receptor Coactivator 1 | 10 | 2009 | 24 | 0.560 |
Why?
|
Animals | 68 | 2024 | 27203 | 0.550 |
Why?
|
Child, Preschool | 17 | 2020 | 3671 | 0.550 |
Why?
|
Prenatal Diagnosis | 3 | 2017 | 110 | 0.530 |
Why?
|
Pituitary Neoplasms | 3 | 2006 | 68 | 0.520 |
Why?
|
Pregnancy | 15 | 2020 | 2995 | 0.510 |
Why?
|
Sudan | 3 | 2020 | 13 | 0.510 |
Why?
|
Serum Albumin | 5 | 2014 | 128 | 0.510 |
Why?
|
Adipose Tissue | 2 | 2014 | 254 | 0.480 |
Why?
|
Adenoma | 3 | 2007 | 243 | 0.480 |
Why?
|
Trans-Activators | 6 | 2006 | 443 | 0.480 |
Why?
|
Genotype | 18 | 2018 | 1867 | 0.480 |
Why?
|
Adult | 45 | 2021 | 26303 | 0.470 |
Why?
|
Gene Expression Regulation | 10 | 2013 | 1976 | 0.470 |
Why?
|
Repressor Proteins | 3 | 2006 | 419 | 0.460 |
Why?
|
Nuclear Proteins | 5 | 2006 | 727 | 0.450 |
Why?
|
Diiodothyronines | 4 | 2015 | 12 | 0.450 |
Why?
|
Propionates | 4 | 2015 | 34 | 0.440 |
Why?
|
Receptors, Thyrotropin | 4 | 2007 | 47 | 0.440 |
Why?
|
Steroids | 1 | 2014 | 175 | 0.430 |
Why?
|
Thyrotoxicosis | 3 | 2004 | 18 | 0.400 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2011 | 31 | 0.400 |
Why?
|
Hyperthyroxinemia | 5 | 2001 | 17 | 0.400 |
Why?
|
Infant, Newborn | 10 | 2021 | 2441 | 0.390 |
Why?
|
Models, Biological | 2 | 2014 | 1764 | 0.380 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 891 | 0.380 |
Why?
|
Infant | 7 | 2020 | 3113 | 0.380 |
Why?
|
Triiodothyronine, Reverse | 8 | 2021 | 32 | 0.380 |
Why?
|
Acute Lung Injury | 1 | 2011 | 64 | 0.380 |
Why?
|
Cushing Syndrome | 4 | 2007 | 24 | 0.370 |
Why?
|
Adolescent | 20 | 2020 | 9141 | 0.370 |
Why?
|
Feedback, Physiological | 2 | 2007 | 63 | 0.360 |
Why?
|
Aldosterone | 3 | 2006 | 56 | 0.360 |
Why?
|
Fibroblasts | 5 | 2009 | 754 | 0.350 |
Why?
|
RNA-Binding Proteins | 4 | 2020 | 258 | 0.350 |
Why?
|
Iodine Radioisotopes | 3 | 2013 | 134 | 0.350 |
Why?
|
Serum | 1 | 2009 | 25 | 0.340 |
Why?
|
Pregnancy Complications | 3 | 2017 | 344 | 0.330 |
Why?
|
Bone and Bones | 7 | 2017 | 266 | 0.320 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 994 | 0.320 |
Why?
|
Thyroidectomy | 1 | 2009 | 170 | 0.320 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 743 | 0.310 |
Why?
|
Homozygote | 6 | 2018 | 202 | 0.310 |
Why?
|
Human Growth Hormone | 4 | 2013 | 54 | 0.310 |
Why?
|
Mothers | 2 | 2017 | 142 | 0.310 |
Why?
|
Enhancer Elements, Genetic | 2 | 2024 | 280 | 0.310 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2007 | 2 | 0.310 |
Why?
|
Heart | 3 | 2002 | 572 | 0.300 |
Why?
|
Prostatic Neoplasms | 6 | 2001 | 1763 | 0.300 |
Why?
|
Amino Acid Substitution | 7 | 2020 | 338 | 0.300 |
Why?
|
Mice, Inbred C57BL | 12 | 2017 | 3198 | 0.290 |
Why?
|
Frameshift Mutation | 3 | 2006 | 51 | 0.290 |
Why?
|
Antithyroid Agents | 3 | 2020 | 20 | 0.290 |
Why?
|
Prolactin | 2 | 2006 | 89 | 0.280 |
Why?
|
Syndrome | 9 | 2010 | 448 | 0.280 |
Why?
|
Drug Resistance | 10 | 2006 | 232 | 0.280 |
Why?
|
Prolactinoma | 1 | 2006 | 8 | 0.280 |
Why?
|
Obesity | 3 | 2008 | 969 | 0.270 |
Why?
|
Skin | 2 | 2009 | 580 | 0.270 |
Why?
|
Saliva | 1 | 2006 | 123 | 0.260 |
Why?
|
Genetic Linkage | 8 | 2008 | 624 | 0.260 |
Why?
|
Middle Aged | 28 | 2018 | 25649 | 0.250 |
Why?
|
Addison Disease | 2 | 2002 | 4 | 0.250 |
Why?
|
Lung | 1 | 2011 | 1243 | 0.250 |
Why?
|
Prealbumin | 2 | 2012 | 34 | 0.250 |
Why?
|
Palpation | 2 | 2001 | 18 | 0.250 |
Why?
|
Base Sequence | 20 | 2006 | 2331 | 0.240 |
Why?
|
Thiazolidinediones | 1 | 2004 | 74 | 0.240 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2024 | 66 | 0.240 |
Why?
|
Cerebellum | 1 | 2006 | 249 | 0.230 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 3 | 2011 | 23 | 0.230 |
Why?
|
Receptors, Steroid | 2 | 2006 | 42 | 0.230 |
Why?
|
RNA, Messenger | 9 | 2011 | 2008 | 0.230 |
Why?
|
Microsatellite Repeats | 1 | 2024 | 148 | 0.230 |
Why?
|
Early Diagnosis | 2 | 2021 | 122 | 0.230 |
Why?
|
Circadian Rhythm | 2 | 2004 | 303 | 0.220 |
Why?
|
Diiodotyrosine | 1 | 2023 | 3 | 0.220 |
Why?
|
Empty Sella Syndrome | 1 | 2003 | 1 | 0.220 |
Why?
|
Bone Development | 5 | 2017 | 35 | 0.220 |
Why?
|
Drug Approval | 1 | 2023 | 66 | 0.220 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 133 | 0.220 |
Why?
|
Pituitary Hormones | 1 | 2002 | 7 | 0.220 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2002 | 6 | 0.220 |
Why?
|
Genetic Predisposition to Disease | 4 | 2021 | 2322 | 0.220 |
Why?
|
Promoter Regions, Genetic | 5 | 2011 | 956 | 0.220 |
Why?
|
Orchitis | 1 | 2002 | 10 | 0.210 |
Why?
|
Epididymitis | 1 | 2002 | 5 | 0.210 |
Why?
|
Propylthiouracil | 3 | 2020 | 24 | 0.210 |
Why?
|
Adrenal Insufficiency | 1 | 2002 | 23 | 0.210 |
Why?
|
Thyroid Nodule | 2 | 2007 | 53 | 0.210 |
Why?
|
Aging | 3 | 2008 | 710 | 0.210 |
Why?
|
Polymerase Chain Reaction | 9 | 2011 | 927 | 0.210 |
Why?
|
Terminology as Topic | 2 | 2014 | 219 | 0.210 |
Why?
|
Acromegaly | 1 | 2002 | 5 | 0.210 |
Why?
|
Diagnosis, Differential | 8 | 2008 | 1586 | 0.210 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 91 | 0.210 |
Why?
|
Molecular Sequence Data | 14 | 2006 | 3029 | 0.210 |
Why?
|
Hypoglycemic Agents | 1 | 2004 | 346 | 0.200 |
Why?
|
Dried Blood Spot Testing | 1 | 2021 | 10 | 0.200 |
Why?
|
Thyrotropin-Releasing Hormone | 5 | 2005 | 40 | 0.190 |
Why?
|
Sequence Analysis, DNA | 4 | 2018 | 863 | 0.190 |
Why?
|
Early Medical Intervention | 1 | 2020 | 20 | 0.190 |
Why?
|
Fetal Therapies | 1 | 2020 | 5 | 0.190 |
Why?
|
Tuberculosis | 1 | 2002 | 121 | 0.190 |
Why?
|
Megalencephaly | 1 | 2020 | 21 | 0.190 |
Why?
|
Family | 2 | 2020 | 322 | 0.190 |
Why?
|
Drugs, Chinese Herbal | 1 | 2001 | 67 | 0.190 |
Why?
|
Gene Expression | 7 | 2015 | 1311 | 0.180 |
Why?
|
Neonatal Screening | 1 | 2021 | 60 | 0.180 |
Why?
|
User-Computer Interface | 1 | 2001 | 187 | 0.180 |
Why?
|
Osteogenesis | 5 | 2007 | 246 | 0.180 |
Why?
|
Gene Frequency | 2 | 2020 | 684 | 0.180 |
Why?
|
Urethral Neoplasms | 1 | 2000 | 10 | 0.180 |
Why?
|
Maternal-Fetal Exchange | 2 | 2017 | 76 | 0.180 |
Why?
|
Cells, Cultured | 7 | 2013 | 2874 | 0.180 |
Why?
|
Penile Neoplasms | 1 | 2000 | 17 | 0.180 |
Why?
|
Constipation | 1 | 2020 | 63 | 0.180 |
Why?
|
Selenoproteins | 1 | 2020 | 20 | 0.180 |
Why?
|
Body Fluids | 1 | 2000 | 35 | 0.180 |
Why?
|
Hormone Replacement Therapy | 3 | 2013 | 82 | 0.180 |
Why?
|
Family Health | 2 | 2018 | 162 | 0.170 |
Why?
|
Protein Isoforms | 5 | 2004 | 273 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 8 | 2020 | 3436 | 0.170 |
Why?
|
Multigene Family | 2 | 1999 | 203 | 0.170 |
Why?
|
Nuclear Receptor Coactivator 3 | 3 | 2004 | 5 | 0.170 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 1999 | 33 | 0.170 |
Why?
|
Heart Aneurysm | 1 | 1999 | 22 | 0.170 |
Why?
|
Animals, Newborn | 4 | 2014 | 523 | 0.170 |
Why?
|
Behcet Syndrome | 1 | 1999 | 15 | 0.170 |
Why?
|
Protein Domains | 1 | 2020 | 131 | 0.170 |
Why?
|
Aneurysm, Ruptured | 1 | 1999 | 52 | 0.170 |
Why?
|
Renal Artery | 1 | 1999 | 52 | 0.170 |
Why?
|
MicroRNAs | 1 | 2024 | 551 | 0.170 |
Why?
|
Phantoms, Imaging | 1 | 2001 | 450 | 0.170 |
Why?
|
Aneurysm, False | 1 | 1999 | 55 | 0.170 |
Why?
|
Cysts | 1 | 2000 | 106 | 0.170 |
Why?
|
Developmental Disabilities | 1 | 2020 | 202 | 0.160 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2001 | 333 | 0.160 |
Why?
|
Nuclear Receptor Coactivator 2 | 3 | 2003 | 16 | 0.160 |
Why?
|
Brain | 7 | 2020 | 2261 | 0.160 |
Why?
|
Haplotypes | 8 | 2015 | 637 | 0.160 |
Why?
|
Radionuclide Imaging | 3 | 2006 | 221 | 0.160 |
Why?
|
Bayes Theorem | 2 | 2001 | 367 | 0.160 |
Why?
|
Germinoma | 1 | 1998 | 3 | 0.160 |
Why?
|
Genetic Association Studies | 1 | 2020 | 294 | 0.160 |
Why?
|
Pregnancy Outcome | 3 | 2017 | 253 | 0.160 |
Why?
|
Cognition | 1 | 2003 | 578 | 0.160 |
Why?
|
Exome | 1 | 2018 | 127 | 0.160 |
Why?
|
Prevalence | 2 | 2020 | 1248 | 0.160 |
Why?
|
Australia | 1 | 2018 | 100 | 0.160 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1998 | 44 | 0.150 |
Why?
|
Sodium | 2 | 1991 | 331 | 0.150 |
Why?
|
Rats | 12 | 2013 | 4034 | 0.150 |
Why?
|
Cattle | 2 | 2009 | 375 | 0.150 |
Why?
|
Amino Acid Sequence | 6 | 2007 | 2062 | 0.150 |
Why?
|
Biomarkers | 2 | 2021 | 1757 | 0.150 |
Why?
|
Insulin Resistance | 2 | 2013 | 363 | 0.150 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 217 | 0.150 |
Why?
|
Research | 2 | 2014 | 251 | 0.150 |
Why?
|
Neoplasm Staging | 2 | 2000 | 1982 | 0.150 |
Why?
|
Fetal Diseases | 1 | 2017 | 82 | 0.150 |
Why?
|
Autoantibodies | 3 | 2010 | 268 | 0.150 |
Why?
|
Leeches | 1 | 1996 | 5 | 0.150 |
Why?
|
Amputation, Traumatic | 1 | 1996 | 9 | 0.140 |
Why?
|
Heart Failure | 1 | 2006 | 1171 | 0.140 |
Why?
|
Aged | 16 | 2013 | 18904 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 1998 | 113 | 0.140 |
Why?
|
Growth | 1 | 1996 | 43 | 0.140 |
Why?
|
Replantation | 1 | 1996 | 36 | 0.140 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2002 | 562 | 0.140 |
Why?
|
Mice, Inbred Strains | 2 | 2011 | 307 | 0.140 |
Why?
|
Penis | 1 | 1996 | 58 | 0.140 |
Why?
|
Cell Differentiation | 6 | 2007 | 1513 | 0.140 |
Why?
|
Cartilage | 3 | 1981 | 115 | 0.140 |
Why?
|
Cholesterol | 6 | 2006 | 354 | 0.140 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 2 | 2006 | 24 | 0.140 |
Why?
|
Protein Folding | 1 | 2018 | 284 | 0.140 |
Why?
|
Lymph Nodes | 1 | 2000 | 547 | 0.140 |
Why?
|
Fibronectins | 3 | 1981 | 102 | 0.130 |
Why?
|
Heart Rate | 4 | 2002 | 492 | 0.130 |
Why?
|
Melanoma | 1 | 2000 | 463 | 0.130 |
Why?
|
Muscle, Skeletal | 4 | 2015 | 464 | 0.130 |
Why?
|
DNA, Complementary | 7 | 2008 | 392 | 0.130 |
Why?
|
Immunohistochemistry | 3 | 2011 | 1790 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 258 | 0.130 |
Why?
|
Young Adult | 5 | 2020 | 6193 | 0.130 |
Why?
|
United States | 3 | 2023 | 6877 | 0.130 |
Why?
|
Thyroxine-Binding Globulin | 1 | 2015 | 6 | 0.130 |
Why?
|
Quality of Life | 4 | 2010 | 1647 | 0.130 |
Why?
|
Sleep | 2 | 2013 | 447 | 0.130 |
Why?
|
Transgender Persons | 1 | 2017 | 102 | 0.130 |
Why?
|
DNA | 11 | 2006 | 1308 | 0.120 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1995 | 80 | 0.120 |
Why?
|
Intellectual Disability | 3 | 1999 | 189 | 0.120 |
Why?
|
Birth Weight | 3 | 2017 | 145 | 0.120 |
Why?
|
Mice, Transgenic | 4 | 2009 | 1570 | 0.120 |
Why?
|
Placenta | 2 | 2014 | 178 | 0.120 |
Why?
|
Mice, Inbred BALB C | 4 | 2011 | 1086 | 0.120 |
Why?
|
Hyperthyroxinemia, Familial Dysalbuminemic | 1 | 2014 | 8 | 0.120 |
Why?
|
Carrier Proteins | 3 | 2006 | 679 | 0.120 |
Why?
|
Carbohydrate Metabolism | 1 | 2014 | 29 | 0.120 |
Why?
|
Academies and Institutes | 1 | 2014 | 31 | 0.120 |
Why?
|
Prostate-Specific Antigen | 4 | 2001 | 358 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 294 | 0.120 |
Why?
|
Research Support as Topic | 1 | 2014 | 82 | 0.110 |
Why?
|
Research Personnel | 1 | 2014 | 70 | 0.110 |
Why?
|
Metabolism, Inborn Errors | 1 | 1993 | 30 | 0.110 |
Why?
|
Muscles | 2 | 1991 | 193 | 0.110 |
Why?
|
Growth Disorders | 2 | 2012 | 63 | 0.110 |
Why?
|
Hypopituitarism | 1 | 2013 | 19 | 0.110 |
Why?
|
Acetates | 1 | 2013 | 65 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2014 | 112 | 0.110 |
Why?
|
Phenols | 1 | 2013 | 41 | 0.110 |
Why?
|
Universities | 1 | 2014 | 146 | 0.110 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 409 | 0.110 |
Why?
|
Anilides | 1 | 2013 | 48 | 0.110 |
Why?
|
Growth and Development | 1 | 2012 | 12 | 0.110 |
Why?
|
Brain Waves | 1 | 2013 | 32 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 2399 | 0.110 |
Why?
|
Glucocorticoids | 2 | 2014 | 358 | 0.110 |
Why?
|
Selenium | 2 | 2010 | 46 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2014 | 199 | 0.110 |
Why?
|
Thyroxine-Binding Proteins | 3 | 1998 | 86 | 0.110 |
Why?
|
Sleep Wake Disorders | 3 | 2010 | 116 | 0.110 |
Why?
|
Cell Nucleus | 3 | 2010 | 594 | 0.100 |
Why?
|
Tumor Cells, Cultured | 4 | 1998 | 1056 | 0.100 |
Why?
|
Disease Progression | 2 | 2007 | 1489 | 0.100 |
Why?
|
Pseudohypoparathyroidism | 1 | 1992 | 5 | 0.100 |
Why?
|
Radioimmunoassay | 3 | 2010 | 155 | 0.100 |
Why?
|
Cerebral Cortex | 2 | 2013 | 588 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 159 | 0.100 |
Why?
|
Iodine | 2 | 2013 | 43 | 0.100 |
Why?
|
Transfection | 5 | 2006 | 912 | 0.100 |
Why?
|
Thyroid Dysgenesis | 1 | 2011 | 9 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2017 | 157 | 0.100 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 57 | 0.100 |
Why?
|
Fatty Liver | 1 | 2013 | 132 | 0.100 |
Why?
|
Muscular Dystrophy, Animal | 1 | 1991 | 21 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2011 | 45 | 0.100 |
Why?
|
Mice, Inbred DBA | 1 | 2011 | 150 | 0.100 |
Why?
|
Hyperinsulinism | 2 | 2013 | 47 | 0.100 |
Why?
|
Orchiectomy | 2 | 2002 | 72 | 0.100 |
Why?
|
Alternative Splicing | 2 | 2004 | 210 | 0.100 |
Why?
|
Chemokines | 1 | 2011 | 74 | 0.100 |
Why?
|
Species Specificity | 2 | 2011 | 685 | 0.100 |
Why?
|
Biopsy | 3 | 2007 | 1187 | 0.100 |
Why?
|
Microsurgery | 1 | 2012 | 85 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 248 | 0.100 |
Why?
|
Mice, Inbred C3H | 1 | 2011 | 371 | 0.100 |
Why?
|
Chromosome Mapping | 4 | 2007 | 1077 | 0.090 |
Why?
|
Osmolar Concentration | 3 | 2007 | 181 | 0.090 |
Why?
|
Adenocarcinoma | 1 | 1998 | 1184 | 0.090 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 2010 | 3 | 0.090 |
Why?
|
Paired Box Transcription Factors | 2 | 2007 | 52 | 0.090 |
Why?
|
Co-Repressor Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
Sodium Channels | 1 | 1991 | 129 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2011 | 698 | 0.090 |
Why?
|
Behavior | 2 | 2003 | 85 | 0.090 |
Why?
|
Carcinoma | 1 | 2013 | 441 | 0.090 |
Why?
|
Research Design | 1 | 2013 | 594 | 0.090 |
Why?
|
Histone Deacetylases | 1 | 2010 | 70 | 0.090 |
Why?
|
Methimazole | 1 | 2009 | 13 | 0.090 |
Why?
|
Hormones | 3 | 2010 | 141 | 0.090 |
Why?
|
Phlebotomy | 1 | 2009 | 21 | 0.090 |
Why?
|
Culture Media | 1 | 2009 | 147 | 0.080 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 88 | 0.080 |
Why?
|
Ultrasonography | 2 | 2002 | 703 | 0.080 |
Why?
|
Time Factors | 8 | 2013 | 5309 | 0.080 |
Why?
|
Fatigue | 1 | 2010 | 178 | 0.080 |
Why?
|
Body Height | 1 | 2009 | 100 | 0.080 |
Why?
|
Alkaline Phosphatase | 4 | 2006 | 133 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2013 | 418 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2009 | 98 | 0.080 |
Why?
|
Autoimmunity | 1 | 2010 | 168 | 0.080 |
Why?
|
Alleles | 4 | 2002 | 1131 | 0.080 |
Why?
|
Genes, Dominant | 2 | 2005 | 117 | 0.080 |
Why?
|
Models, Animal | 2 | 2013 | 276 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2017 | 902 | 0.080 |
Why?
|
Prospective Studies | 4 | 2006 | 4268 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 269 | 0.080 |
Why?
|
Creatine Kinase | 2 | 2005 | 52 | 0.080 |
Why?
|
Biological Transport | 3 | 2014 | 399 | 0.080 |
Why?
|
Lymph Node Excision | 2 | 2000 | 221 | 0.080 |
Why?
|
Weight-Bearing | 1 | 2008 | 67 | 0.080 |
Why?
|
Hypothalamus | 2 | 2006 | 79 | 0.080 |
Why?
|
Glycoproteins | 1 | 2009 | 235 | 0.080 |
Why?
|
Random Allocation | 2 | 2017 | 329 | 0.080 |
Why?
|
Hypophysectomy | 1 | 2007 | 27 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2021 | 8869 | 0.080 |
Why?
|
Rats, Inbred Dahl | 1 | 2007 | 8 | 0.080 |
Why?
|
Litter Size | 1 | 2007 | 13 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2001 | 2019 | 0.080 |
Why?
|
Rats, Inbred BN | 1 | 2007 | 38 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2010 | 1156 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2010 | 697 | 0.080 |
Why?
|
Cytokines | 1 | 2011 | 801 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2008 | 104 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 2632 | 0.070 |
Why?
|
Homeostasis | 2 | 2010 | 408 | 0.070 |
Why?
|
Plasmids | 2 | 2006 | 292 | 0.070 |
Why?
|
Follicle Stimulating Hormone | 2 | 2010 | 147 | 0.070 |
Why?
|
Chromosomes | 1 | 2007 | 97 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 741 | 0.070 |
Why?
|
Receptor, Melanocortin, Type 2 | 1 | 2006 | 1 | 0.070 |
Why?
|
Animals, Genetically Modified | 1 | 2007 | 182 | 0.070 |
Why?
|
Oxidoreductases | 1 | 2007 | 112 | 0.070 |
Why?
|
Angiotensin II | 1 | 2006 | 93 | 0.070 |
Why?
|
Risk Factors | 2 | 2014 | 5439 | 0.070 |
Why?
|
Hyperplasia | 1 | 2006 | 152 | 0.070 |
Why?
|
Muscle Development | 1 | 1986 | 41 | 0.070 |
Why?
|
Introns | 1 | 2007 | 298 | 0.070 |
Why?
|
Mosaicism | 1 | 2006 | 70 | 0.070 |
Why?
|
Adrenalectomy | 1 | 2006 | 45 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 73 | 0.070 |
Why?
|
Up-Regulation | 2 | 2006 | 729 | 0.070 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 20 | 0.070 |
Why?
|
Antioxidants | 1 | 2007 | 225 | 0.070 |
Why?
|
Osteoporosis | 1 | 2007 | 122 | 0.070 |
Why?
|
Ferritins | 1 | 2005 | 29 | 0.060 |
Why?
|
In Situ Hybridization | 3 | 2011 | 312 | 0.060 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2005 | 17 | 0.060 |
Why?
|
Primates | 2 | 2024 | 155 | 0.060 |
Why?
|
Myocardium | 3 | 2003 | 570 | 0.060 |
Why?
|
Genes, Reporter | 1 | 2006 | 275 | 0.060 |
Why?
|
DNA Damage | 1 | 2007 | 371 | 0.060 |
Why?
|
Pro-Opiomelanocortin | 1 | 2004 | 13 | 0.060 |
Why?
|
Body Temperature | 1 | 2005 | 125 | 0.060 |
Why?
|
Cyclic AMP | 3 | 2011 | 274 | 0.060 |
Why?
|
Lymphatic Metastasis | 2 | 2013 | 499 | 0.060 |
Why?
|
Ion Channels | 1 | 1986 | 246 | 0.060 |
Why?
|
Pituitary-Adrenal System | 1 | 2004 | 64 | 0.060 |
Why?
|
Bone Resorption | 2 | 2007 | 42 | 0.060 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2007 | 206 | 0.060 |
Why?
|
PPAR gamma | 1 | 2004 | 74 | 0.060 |
Why?
|
Embryo, Mammalian | 3 | 2014 | 221 | 0.060 |
Why?
|
Cross-Over Studies | 2 | 2013 | 390 | 0.060 |
Why?
|
5' Untranslated Regions | 1 | 2004 | 51 | 0.060 |
Why?
|
Treatment Failure | 1 | 2004 | 289 | 0.060 |
Why?
|
Radiosurgery | 1 | 2007 | 280 | 0.060 |
Why?
|
Acetyltransferases | 1 | 2004 | 32 | 0.060 |
Why?
|
Abortion, Spontaneous | 1 | 2004 | 66 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2004 | 61 | 0.060 |
Why?
|
Pituitary Gland, Anterior | 2 | 1999 | 22 | 0.060 |
Why?
|
Monoiodotyrosine | 1 | 2023 | 4 | 0.060 |
Why?
|
Pregnancy, Animal | 1 | 2003 | 58 | 0.060 |
Why?
|
Gene Silencing | 1 | 2004 | 178 | 0.060 |
Why?
|
Florida | 1 | 2023 | 56 | 0.050 |
Why?
|
Radiography | 2 | 2003 | 806 | 0.050 |
Why?
|
Estradiol | 2 | 2002 | 251 | 0.050 |
Why?
|
Egypt | 1 | 2002 | 13 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2001 | 2405 | 0.050 |
Why?
|
Pulsatile Flow | 1 | 2002 | 50 | 0.050 |
Why?
|
Genes, erbA | 2 | 2017 | 10 | 0.050 |
Why?
|
Markov Chains | 2 | 2001 | 126 | 0.050 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 231 | 0.050 |
Why?
|
Isoelectric Focusing | 1 | 2002 | 39 | 0.050 |
Why?
|
Receptors, Retinoic Acid | 1 | 2002 | 46 | 0.050 |
Why?
|
Protein Biosynthesis | 2 | 2009 | 391 | 0.050 |
Why?
|
Consanguinity | 2 | 1999 | 73 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2000 | 1214 | 0.050 |
Why?
|
Response Elements | 1 | 2002 | 65 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 3653 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 21 | 0.050 |
Why?
|
Leptin | 1 | 2002 | 105 | 0.050 |
Why?
|
Odds Ratio | 2 | 2017 | 685 | 0.050 |
Why?
|
Testis | 1 | 2002 | 152 | 0.050 |
Why?
|
Central Nervous System Diseases | 1 | 2002 | 52 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2013 | 8151 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 219 | 0.050 |
Why?
|
Albuminuria | 1 | 2001 | 48 | 0.050 |
Why?
|
Weight Gain | 1 | 2002 | 122 | 0.050 |
Why?
|
Pilot Projects | 2 | 2001 | 865 | 0.050 |
Why?
|
Calcitonin | 1 | 1981 | 39 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 1860 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 72 | 0.050 |
Why?
|
Glucose Tolerance Test | 1 | 2002 | 227 | 0.050 |
Why?
|
Psychometrics | 1 | 2003 | 328 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 114 | 0.050 |
Why?
|
Gene Dosage | 1 | 2002 | 208 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2002 | 235 | 0.050 |
Why?
|
Albumins | 1 | 2001 | 130 | 0.050 |
Why?
|
Genes, bcl-2 | 1 | 2001 | 16 | 0.050 |
Why?
|
Retinoids | 1 | 2001 | 18 | 0.050 |
Why?
|
Leukocytes | 1 | 2002 | 203 | 0.050 |
Why?
|
Immunotherapy, Active | 1 | 2001 | 15 | 0.050 |
Why?
|
Somatostatin | 1 | 1981 | 55 | 0.050 |
Why?
|
Body Weight | 1 | 2002 | 452 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 266 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2003 | 507 | 0.050 |
Why?
|
Amniotic Fluid | 1 | 2020 | 30 | 0.050 |
Why?
|
Genes, p53 | 1 | 2001 | 109 | 0.050 |
Why?
|
Electrophysiology | 2 | 1991 | 402 | 0.050 |
Why?
|
Interferons | 1 | 2001 | 134 | 0.050 |
Why?
|
Affect | 1 | 2003 | 387 | 0.050 |
Why?
|
Bone Matrix | 1 | 1980 | 19 | 0.050 |
Why?
|
Urinary Reservoirs, Continent | 1 | 2000 | 14 | 0.040 |
Why?
|
Urology | 1 | 2001 | 117 | 0.040 |
Why?
|
Suction | 1 | 2000 | 35 | 0.040 |
Why?
|
Needles | 1 | 2000 | 36 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2002 | 195 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 1981 | 259 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 136 | 0.040 |
Why?
|
Membrane Potentials | 2 | 1991 | 436 | 0.040 |
Why?
|
Urinary Diversion | 1 | 2000 | 42 | 0.040 |
Why?
|
Forecasting | 1 | 2001 | 305 | 0.040 |
Why?
|
Phytotherapy | 1 | 2001 | 135 | 0.040 |
Why?
|
Adipose Tissue, Brown | 2 | 2013 | 86 | 0.040 |
Why?
|
Reference Values | 2 | 2010 | 665 | 0.040 |
Why?
|
Gene Deletion | 1 | 2001 | 342 | 0.040 |
Why?
|
Oxidation-Reduction | 2 | 2013 | 382 | 0.040 |
Why?
|
Tanzania | 1 | 1999 | 46 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 1999 | 57 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2000 | 110 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 477 | 0.040 |
Why?
|
Testosterone | 1 | 2001 | 275 | 0.040 |
Why?
|
Comorbidity | 1 | 2003 | 947 | 0.040 |
Why?
|
Christianity | 1 | 1999 | 37 | 0.040 |
Why?
|
Tetrodotoxin | 2 | 1991 | 50 | 0.040 |
Why?
|
Bone Marrow | 1 | 1981 | 444 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2001 | 277 | 0.040 |
Why?
|
Laparoscopy | 1 | 2006 | 762 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2000 | 216 | 0.040 |
Why?
|
Plant Extracts | 1 | 2001 | 244 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 1999 | 186 | 0.040 |
Why?
|
Osteoblasts | 3 | 2007 | 96 | 0.040 |
Why?
|
Likelihood Functions | 1 | 1999 | 252 | 0.040 |
Why?
|
Rectum | 1 | 1999 | 148 | 0.040 |
Why?
|
History, 20th Century | 1 | 2000 | 307 | 0.040 |
Why?
|
Collagen | 1 | 1980 | 295 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 824 | 0.040 |
Why?
|
Exons | 3 | 1998 | 452 | 0.040 |
Why?
|
Isotretinoin | 1 | 1997 | 23 | 0.040 |
Why?
|
Placental Circulation | 1 | 2017 | 11 | 0.040 |
Why?
|
Pain Measurement | 1 | 1999 | 329 | 0.040 |
Why?
|
DNA Primers | 2 | 1999 | 543 | 0.040 |
Why?
|
Sampling Studies | 1 | 2017 | 72 | 0.040 |
Why?
|
Blotting, Western | 2 | 2011 | 797 | 0.040 |
Why?
|
Kinetics | 3 | 2006 | 1528 | 0.040 |
Why?
|
Fetal Development | 1 | 2017 | 31 | 0.040 |
Why?
|
Chondrocytes | 1 | 2017 | 63 | 0.040 |
Why?
|
Echocardiography | 1 | 2002 | 933 | 0.040 |
Why?
|
Papanicolaou Test | 1 | 2017 | 39 | 0.040 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1996 | 7 | 0.040 |
Why?
|
Adrenal Cortex Diseases | 1 | 1996 | 6 | 0.040 |
Why?
|
COS Cells | 3 | 2004 | 167 | 0.040 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1996 | 31 | 0.040 |
Why?
|
Selection, Genetic | 1 | 2001 | 509 | 0.040 |
Why?
|
Suramin | 1 | 1996 | 27 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2017 | 70 | 0.040 |
Why?
|
Interferon-alpha | 1 | 1997 | 235 | 0.040 |
Why?
|
Pandemics | 1 | 2023 | 760 | 0.040 |
Why?
|
Dependovirus | 1 | 2016 | 34 | 0.040 |
Why?
|
PAX8 Transcription Factor | 2 | 2007 | 23 | 0.040 |
Why?
|
Cystectomy | 1 | 1997 | 105 | 0.040 |
Why?
|
Valine | 1 | 1996 | 62 | 0.030 |
Why?
|
Down-Regulation | 3 | 2003 | 519 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 1704 | 0.030 |
Why?
|
Ureter | 1 | 1997 | 93 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 1999 | 255 | 0.030 |
Why?
|
Mass Screening | 1 | 2001 | 631 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2017 | 155 | 0.030 |
Why?
|
Patient Preference | 1 | 2017 | 108 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1993 | 127 | 0.030 |
Why?
|
Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2015 | 4 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2020 | 1848 | 0.030 |
Why?
|
Self Care | 1 | 2017 | 164 | 0.030 |
Why?
|
Models, Genetic | 1 | 2001 | 942 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2017 | 2343 | 0.030 |
Why?
|
Drinking | 1 | 2015 | 33 | 0.030 |
Why?
|
AIDS Dementia Complex | 1 | 1995 | 8 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2015 | 101 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 1142 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 1997 | 321 | 0.030 |
Why?
|
Logistic Models | 1 | 1999 | 1204 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1997 | 491 | 0.030 |
Why?
|
Glutathione Transferase | 1 | 2015 | 112 | 0.030 |
Why?
|
Organ Specificity | 2 | 2012 | 272 | 0.030 |
Why?
|
Educational Status | 1 | 1995 | 191 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2001 | 834 | 0.030 |
Why?
|
Molecular Probes | 1 | 1995 | 35 | 0.030 |
Why?
|
Isoenzymes | 1 | 2015 | 272 | 0.030 |
Why?
|
Stents | 1 | 1997 | 391 | 0.030 |
Why?
|
Eating | 1 | 2015 | 165 | 0.030 |
Why?
|
United States Government Agencies | 1 | 2014 | 2 | 0.030 |
Why?
|
Financing, Government | 1 | 2014 | 24 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1994 | 156 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2007 | 140 | 0.030 |
Why?
|
Rats, Wistar | 2 | 2007 | 302 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2014 | 292 | 0.030 |
Why?
|
Psychological Tests | 1 | 1994 | 91 | 0.030 |
Why?
|
Genetic Therapy | 1 | 2016 | 357 | 0.030 |
Why?
|
Public Policy | 1 | 2014 | 52 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 260 | 0.030 |
Why?
|
Proline | 1 | 1994 | 57 | 0.030 |
Why?
|
Cerebrum | 1 | 2013 | 16 | 0.030 |
Why?
|
Genome | 1 | 1997 | 384 | 0.030 |
Why?
|
Amino Acid Transport System y+L | 1 | 2013 | 3 | 0.030 |
Why?
|
Canada | 1 | 2014 | 205 | 0.030 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2013 | 5 | 0.030 |
Why?
|
Fusion Regulatory Protein 1, Light Chains | 1 | 2013 | 6 | 0.030 |
Why?
|
Amino Acid Transport System y+ | 1 | 2013 | 7 | 0.030 |
Why?
|
Codon | 2 | 2009 | 122 | 0.030 |
Why?
|
Glucose Transporter Type 4 | 1 | 2013 | 17 | 0.030 |
Why?
|
Base Composition | 1 | 1993 | 35 | 0.030 |
Why?
|
Gluconeogenesis | 1 | 2013 | 14 | 0.030 |
Why?
|
Serine | 1 | 1994 | 102 | 0.030 |
Why?
|
Organic Cation Transport Proteins | 1 | 2013 | 13 | 0.030 |
Why?
|
Algorithms | 1 | 2002 | 1864 | 0.030 |
Why?
|
Arginine | 2 | 2009 | 138 | 0.030 |
Why?
|
Organic Anion Transporters | 1 | 2013 | 26 | 0.030 |
Why?
|
Endocrine System Diseases | 1 | 1993 | 23 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2014 | 123 | 0.030 |
Why?
|
Body Composition | 1 | 2013 | 70 | 0.030 |
Why?
|
Bangladesh | 1 | 2014 | 323 | 0.030 |
Why?
|
Double-Blind Method | 1 | 1997 | 1712 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2013 | 150 | 0.030 |
Why?
|
Compassionate Use Trials | 1 | 2012 | 8 | 0.030 |
Why?
|
Urea | 1 | 2012 | 58 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 42 | 0.030 |
Why?
|
Genes | 1 | 1993 | 305 | 0.030 |
Why?
|
Polysomnography | 1 | 2013 | 150 | 0.030 |
Why?
|
Triglycerides | 1 | 2013 | 231 | 0.030 |
Why?
|
Dietary Fats | 1 | 2013 | 136 | 0.030 |
Why?
|
Diseases in Twins | 1 | 2012 | 65 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2017 | 394 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2012 | 155 | 0.030 |
Why?
|
Leucine | 1 | 1992 | 67 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2012 | 6713 | 0.030 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1992 | 53 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2012 | 89 | 0.030 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2012 | 44 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2013 | 171 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2012 | 87 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1993 | 647 | 0.030 |
Why?
|
Ligands | 2 | 2003 | 440 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 863 | 0.020 |
Why?
|
Cell Line | 2 | 2010 | 2498 | 0.020 |
Why?
|
Basal Metabolism | 1 | 1990 | 20 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 376 | 0.020 |
Why?
|
Child Development | 1 | 2012 | 166 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2011 | 95 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2011 | 282 | 0.020 |
Why?
|
Tretinoin | 1 | 1991 | 128 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 2535 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2010 | 171 | 0.020 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1992 | 169 | 0.020 |
Why?
|
Sleep, REM | 1 | 2010 | 51 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 1236 | 0.020 |
Why?
|
Sleep Stages | 1 | 2010 | 47 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2005 | 1020 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2010 | 167 | 0.020 |
Why?
|
Ileum | 2 | 2001 | 162 | 0.020 |
Why?
|
Acetylation | 1 | 2010 | 132 | 0.020 |
Why?
|
Risk Assessment | 1 | 2017 | 2285 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2012 | 2282 | 0.020 |
Why?
|
Ghana | 1 | 2009 | 4 | 0.020 |
Why?
|
Prognosis | 1 | 2017 | 3749 | 0.020 |
Why?
|
Hematopoiesis | 2 | 1981 | 164 | 0.020 |
Why?
|
Cell Division | 2 | 1981 | 696 | 0.020 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2013 | 221 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 289 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 1997 | 1520 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2010 | 129 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2012 | 497 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 379 | 0.020 |
Why?
|
Methylation | 1 | 2010 | 266 | 0.020 |
Why?
|
Codon, Terminator | 2 | 1999 | 22 | 0.020 |
Why?
|
Chicago | 1 | 2013 | 1408 | 0.020 |
Why?
|
Regression Analysis | 1 | 2010 | 594 | 0.020 |
Why?
|
Blood Glucose | 1 | 2012 | 840 | 0.020 |
Why?
|
Trinidad and Tobago | 1 | 2008 | 4 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2012 | 1048 | 0.020 |
Why?
|
Histones | 1 | 2010 | 327 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1992 | 394 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2007 | 33 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2007 | 24 | 0.020 |
Why?
|
Osteoclasts | 1 | 2007 | 34 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2013 | 2744 | 0.020 |
Why?
|
Chromatin | 1 | 2010 | 396 | 0.020 |
Why?
|
Uracil | 1 | 2007 | 56 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 1351 | 0.020 |
Why?
|
Puberty, Precocious | 1 | 2007 | 36 | 0.020 |
Why?
|
Neuroblastoma | 1 | 1991 | 394 | 0.020 |
Why?
|
Mutagenesis | 1 | 2007 | 200 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1992 | 1944 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2008 | 333 | 0.020 |
Why?
|
Cohort Studies | 1 | 2013 | 2833 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2007 | 159 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1986 | 144 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2006 | 147 | 0.020 |
Why?
|
Protein Binding | 1 | 2010 | 1484 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2006 | 122 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2012 | 1842 | 0.020 |
Why?
|
Bone Density | 1 | 2007 | 209 | 0.020 |
Why?
|
Turkey | 1 | 2005 | 21 | 0.020 |
Why?
|
Electric Stimulation | 1 | 1986 | 354 | 0.020 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 33 | 0.020 |
Why?
|
Sequence Deletion | 2 | 1998 | 205 | 0.020 |
Why?
|
Siblings | 1 | 2005 | 111 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 283 | 0.020 |
Why?
|
Acclimatization | 1 | 2005 | 76 | 0.020 |
Why?
|
Thermogenesis | 1 | 2005 | 41 | 0.020 |
Why?
|
Cold Temperature | 1 | 2005 | 160 | 0.020 |
Why?
|
Azores | 1 | 2004 | 3 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 332 | 0.020 |
Why?
|
DNA Repair | 1 | 2007 | 359 | 0.020 |
Why?
|
Thermodynamics | 1 | 2005 | 309 | 0.020 |
Why?
|
Norepinephrine | 1 | 2005 | 170 | 0.020 |
Why?
|
Dimerization | 1 | 2004 | 143 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2005 | 241 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2005 | 995 | 0.010 |
Why?
|
Temperature | 1 | 2005 | 401 | 0.010 |
Why?
|
Wakefulness | 1 | 2004 | 134 | 0.010 |
Why?
|
Fetal Resorption | 1 | 2003 | 2 | 0.010 |
Why?
|
Liver Neoplasms | 2 | 2004 | 770 | 0.010 |
Why?
|
Freund's Adjuvant | 1 | 2003 | 26 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 2004 | 338 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2005 | 231 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2003 | 244 | 0.010 |
Why?
|
Immunization | 1 | 2003 | 160 | 0.010 |
Why?
|
Rats, Zucker | 1 | 2002 | 38 | 0.010 |
Why?
|
Retinoid X Receptors | 1 | 2002 | 39 | 0.010 |
Why?
|
Tetrahydronaphthalenes | 1 | 2002 | 16 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 28 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 1688 | 0.010 |
Why?
|
Thyroid Nuclear Factor 1 | 1 | 2002 | 12 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 3366 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2003 | 371 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 259 | 0.010 |
Why?
|
Growth Hormone | 1 | 2002 | 97 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 1981 | 33 | 0.010 |
Why?
|
Glucuronidase | 1 | 1981 | 21 | 0.010 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 18 | 0.010 |
Why?
|
Hypothermia | 1 | 2001 | 26 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 72 | 0.010 |
Why?
|
Deafness | 1 | 2001 | 47 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2001 | 65 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 1295 | 0.010 |
Why?
|
Calcium Chloride | 1 | 1981 | 9 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2001 | 88 | 0.010 |
Why?
|
HIV | 1 | 2001 | 48 | 0.010 |
Why?
|
Thymidine | 1 | 1981 | 59 | 0.010 |
Why?
|
Movement Disorders | 1 | 2001 | 44 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2001 | 306 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2001 | 106 | 0.010 |
Why?
|
Switzerland | 1 | 2000 | 17 | 0.010 |
Why?
|
Proteoglycans | 1 | 1981 | 123 | 0.010 |
Why?
|
Gelatin | 1 | 1980 | 25 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2004 | 405 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2001 | 247 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 531 | 0.010 |
Why?
|
Feedback | 1 | 2001 | 134 | 0.010 |
Why?
|
Extracellular Space | 1 | 2000 | 91 | 0.010 |
Why?
|
DNA Replication | 1 | 1981 | 169 | 0.010 |
Why?
|
HeLa Cells | 1 | 2001 | 505 | 0.010 |
Why?
|
Receptors, Corticotropin | 1 | 1999 | 5 | 0.010 |
Why?
|
Osteocytes | 1 | 1979 | 9 | 0.010 |
Why?
|
Goldfish | 1 | 1979 | 6 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1999 | 63 | 0.010 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2000 | 28 | 0.010 |
Why?
|
Lung Diseases | 1 | 2002 | 269 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1981 | 425 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1980 | 324 | 0.010 |
Why?
|
Genetic Markers | 1 | 2000 | 478 | 0.010 |
Why?
|
Reference Standards | 1 | 1999 | 143 | 0.010 |
Why?
|
Intestine, Small | 1 | 2001 | 304 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1998 | 67 | 0.010 |
Why?
|
Antibodies | 1 | 1981 | 354 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 2531 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2000 | 691 | 0.010 |
Why?
|
DNA, Antisense | 1 | 1998 | 15 | 0.010 |
Why?
|
Endocrine Glands | 1 | 1997 | 13 | 0.010 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 1998 | 43 | 0.010 |
Why?
|
Xenopus | 1 | 1998 | 126 | 0.010 |
Why?
|
Fishes | 1 | 1979 | 137 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 1998 | 174 | 0.010 |
Why?
|
Protein Conformation | 1 | 2000 | 884 | 0.010 |
Why?
|
Nerve Net | 1 | 2001 | 367 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1997 | 147 | 0.010 |
Why?
|
Cell Membrane | 1 | 2000 | 669 | 0.010 |
Why?
|
Cosyntropin | 1 | 1996 | 5 | 0.010 |
Why?
|
Genetic Variation | 1 | 2004 | 1369 | 0.010 |
Why?
|
Epilepsy | 1 | 2001 | 421 | 0.010 |
Why?
|
Calcium | 1 | 1981 | 1170 | 0.010 |
Why?
|
RNA Splicing | 1 | 1998 | 150 | 0.010 |
Why?
|
Postoperative Care | 1 | 1997 | 230 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 565 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 39 | 0.010 |
Why?
|
Lymphocytes | 1 | 1998 | 470 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1995 | 146 | 0.010 |
Why?
|
Personality Assessment | 1 | 1995 | 97 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 1170 | 0.010 |
Why?
|
Intelligence | 1 | 1995 | 71 | 0.010 |
Why?
|
Child Behavior Disorders | 1 | 1995 | 76 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1996 | 902 | 0.010 |
Why?
|
Histidine | 1 | 1994 | 56 | 0.010 |
Why?
|
Prostatectomy | 1 | 1997 | 476 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2000 | 1401 | 0.010 |
Why?
|
Hepatoblastoma | 1 | 1993 | 12 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1 | 1 | 1993 | 30 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 1993 | 34 | 0.010 |
Why?
|
RNA | 1 | 1998 | 575 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1993 | 65 | 0.010 |
Why?
|
Niacin | 1 | 1993 | 37 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 137 | 0.010 |
Why?
|
CHO Cells | 1 | 1993 | 187 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 1993 | 80 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 1993 | 68 | 0.010 |
Why?
|
Cricetinae | 1 | 1993 | 560 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1993 | 153 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 269 | 0.010 |
Why?
|
Laminin | 1 | 1992 | 89 | 0.010 |
Why?
|
Gene Amplification | 1 | 1992 | 133 | 0.010 |
Why?
|
Dexamethasone | 1 | 1993 | 344 | 0.010 |
Why?
|
Binding Sites | 1 | 1993 | 1113 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1992 | 575 | 0.010 |
Why?
|
Mice, Nude | 1 | 1992 | 814 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1993 | 539 | 0.010 |
Why?
|
Cell Movement | 1 | 1992 | 783 | 0.000 |
Why?
|